Exploratory findings from a prematurely closed international, multicentre, academic trial: RAVELLO, a phase III study of regorafenib versus placebo as maintenance therapy after first-line treatment in RAS wild-type metastatic colorectal cancer

  1. Cardone, C.
  2. Martinelli, E.
  3. Troiani, T.
  4. Sforza, V.
  5. Avallone, A.
  6. Nappi, A.
  7. Montesarchio, V.
  8. Andreozzi, F.
  9. Biglietto, M.
  10. Calabrese, F.
  11. Bordonaro, R.
  12. Cordio, S.
  13. Bregni, G.
  14. Febbraro, A.
  15. Garcia-Carbonero, R.
  16. Feliu, J.
  17. Cervantes, A.
  18. Ciardiello, F.
Revista:
ESMO Open

ISSN: 2059-7029

Any de publicació: 2019

Volum: 4

Número: 4

Tipus: Article

DOI: 10.1136/ESMOOPEN-2019-000519 GOOGLE SCHOLAR lock_openAccés obert editor
Font de les dades: Scopus